A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Kineta Inc.
Shanghai Yunying Medical Technology
Revolution Medicines, Inc.
Imperial College London
Corregene Biotechnology Co., Ltd
Shanghai Fengxian District Central Hospital
Karolinska Institutet
SpeciCare
University Hospital Tuebingen
Petra Pharma
Samyang Biopharmaceuticals Corporation
Instituto do Cancer do Estado de São Paulo
Instituto do Cancer do Estado de São Paulo
Critical Outcome Technologies Inc.
Mie University
Poniard Pharmaceuticals